A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
Not yet recruiting · NCT07227103 · Registry updated 2026-09-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial | Depressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-25 | NCT07227103 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| HOPE Therapeutics, Inc. | 1 |
| neurocare group AG | 1 |
| NeuroRx, Inc. | 1 |
| Zeta Surgical, Inc. | 1 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cohen and Associates | Sarasota | United States | 1 |
| Harvard Mclean Hospital | Belmont | United States | 1 |
| HOPE Accelerated Care | West Palm Beach | United States | 1 |